Breast Cancer: A 3047% Risk Reduction Among the most clinically significant findings was a real-world cohort study presented at ASCO 2026, which reported that women with Type 2 diabetes or obesity using GLP-1 receptor agonists experienced a 30 to 47% reduction in breast cancer risk compared to non-users
Do not rinse after application
Sign In Sign Out My Account Subscribe BioWorld - Tuesday, July 28, 2026 See today's BioWorld Home Viking to push oral GLP-1/GIP drug into phase III obesity trial To read the full story, subscribe or sign in
From our data, it appears that nematocyte production is limited to a large clade within the genus Drosophila, but given the unknown position of the Zaprionus lineage within Drosophila we cannot yet determine whether nematocytes are a synapomorphy for the subgenus Drosophila
It is thought that the loss of incretin effect is from (1) a reduction in secretion of incretin hormone in response to nutrients (hyposecretion) and/or (2) a reduction in insulinotropic effect on pancreatic beta cells (insulin resistance)
Many owners look for steadier patternsmore consistent appetite, better tolerance of routine stress, and fewer down daysrather than a sudden, obvious shift
